New horizons for targeted treatment of neuroendocrine tumors.

about

Potentiation of 177Lu-octreotate peptide receptor radionuclide therapy of human neuroendocrine tumor cells by PARP inhibitor.

P2860

Q55312290-69C8C772-1D67-40E6-926E-5A81222E64F2

P2860

New horizons for targeted treatment of neuroendocrine tumors.

Item

http://www.wikidata.org/entity/Q38750685

description

2016 nî lūn-bûn

@nan

2016年の論文

@ja

2016年論文

@yue

2016年論文

@zh-hant

2016年論文

@zh-hk

2016年論文

@zh-mo

2016年論文

@zh-tw

2016年论文

@wuu

2016年论文

@zh

2016年论文

@zh-cn

name

New horizons for targeted treatment of neuroendocrine tumors.

@en

type

Item

label

New horizons for targeted treatment of neuroendocrine tumors.

@en

prefLabel

New horizons for targeted treatment of neuroendocrine tumors.

@en

P1476

New horizons for targeted treatment of neuroendocrine tumors.

@en

P2093

Alberto Mangano

http://www.w3.org/2001/XMLSchema#string

Dimitrios H Roukos

http://www.w3.org/2001/XMLSchema#string

Georgios D Lianos

http://www.w3.org/2001/XMLSchema#string

Gianlorenzo Dionigi

http://www.w3.org/2001/XMLSchema#string

Hoon Yub Kim

http://www.w3.org/2001/XMLSchema#string

Sam E Mason

http://www.w3.org/2001/XMLSchema#string

P2860

Intratumor heterogeneity: evolution through space and time

New strategies for advanced neuroendocrine tumors in the era of targeted therapy

GEP-NETS update: functional localisation and scintigraphy in neuroendocrine tumours of the gastrointestinal tract and pancreas (GEP-NETs)

The pathologic classification of neuroendocrine tumors: a review of nomenclature, grading, and staging systems

DAXX/ATRX, MEN1, and mTOR pathway genes are frequently altered in pancreatic neuroendocrine tumors

Current knowledge on diagnosis and staging of neuroendocrine tumors

Bevacizumab-based combination therapy for advanced gastroenteropancreatic neuroendocrine neoplasms (GEP-NENs): a systematic review of the literature.

Sunitinib malate for the treatment of pancreatic neuroendocrine tumors.

Altered telomeres in tumors with ATRX and DAXX mutations.

ENETS Consensus Guidelines for the management of patients with digestive neuroendocrine neoplasms of the digestive system: well-differentiated pancreatic non-functioning tumors.

P304

1059-1065

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.2217/FON.16.8

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2016-02-26T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

26916705

http://www.w3.org/2001/XMLSchema#string

New horizons for targeted treatment of neuroendocrine tumors.

about

P2860

P2860

New horizons for targeted treatment of neuroendocrine tumors.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P577

P698

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P577

P698